GLP-1 receptor agonists on WHO-EML 2025 list: major breakthrough bounded by persistent challenge
Crossref DOI link: https://doi.org/10.1007/s40200-025-01810-6
Published Online: 2025-12-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mani, Kanimozhi
Text and Data Mining valid from 2025-12-04
Version of Record valid from 2025-12-04
Article History
Received: 5 November 2025
Accepted: 24 November 2025
First Online: 4 December 2025
Declarations
:
: The authors declare no competing interests.